Evidence map›Paper›PMID 40843706›Full record

ReviewEpidemiologia (Basel, Switzerland)2025

The Prevalence of

Dmitrii N Andreev, Alsu R Khurmatullina, Igor V Maev, Dmitry S Bordin, Sayar R Abdulkhakov, Yury A Kucheryavyy, Petr A Beliy, Filipp S Sokolov

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Epidemiologia (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Social determinants of health andFrontiers in public health · 2025
    Pooled it
  2. Article
  3. Article
  4. Efficacy and Safety of Tegoprazan inPharmaceuticals (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dmitrii N AndreevDepartment of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.ORCID 0000-0002-4007-7112
Alsu R KhurmatullinaDepartment of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.ORCID 0009-0000-4358-7823
Igor V MaevDepartment of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.
Dmitry S BordinDepartment of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.ORCID 0000-0003-2815-3992
Sayar R AbdulkhakovDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, 420008 Kazan, Russia.ORCID 0000-0001-9542-3580
Yury A KucheryavyyIlyinskaya Hospital, 143421 Krasnogorsk, Russia.ORCID 0000-0001-7760-2091
Petr A BeliyDepartment of Internal Disease Propaedeutics and Gastroenterology, Russian University of Medicine, 127473 Moscow, Russia.
Filipp S SokolovDepartment of Pharmacology, Russian University of Medicine, 127473 Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dynamicsepidemiologyeradicationH. pyloriprevalenceRussia

Identifiers

PMID40843706
PMCPMC12372033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.